Format

Send to

Choose Destination
World J Urol. 2003 Nov;21(5):325-37. Epub 2003 Oct 29.

Androgens and prostate cancer.

Author information

1
The Prostate Centre at the Vancouver General Hospital, University of British Columbia, 2660-Oak Street, Vancouver, BC, V6H 3Z6 Canada. aso@vanhosp.bc.ca

Abstract

Over 60 years ago Huggins and Hodges demonstrated the importance of androgens and prostate cancer. Since then, significant research has revealed that this relationship is multi-faceted and is interwoven with different signaling cascades and protein coactivators. The complex interrelationship between hormone and cancer is best exemplified by the recurrence and progression of prostate cancer after hormonal therapy to a lethally resistant phenotype despite initially encouraging therapeutic responses. If we are to significantly improve survival with novel therapies, further understanding of the emergence of this resistant phenotype is essential. The purpose of this article is to review the mechanisms of androgen action and its relation to hormonal therapy and mechanisms of hormonal resistance.

PMID:
14586548
DOI:
10.1007/s00345-003-0373-9
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center